ArticleJGH open : an open access journal of gastroenterology and hepatology2023

Efficacy and safety of saroglitazar in real-world patients of non-alcoholic fatty liver disease with or without diabetes including compensated cirrhosis: A tertiary care center experience.

Sujit Chaudhuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.